EGFR and neoplasm: Here, we found that in subtype-1 tumours various phosphoproteins that participant in mTOR signalling – such as MTOR-pS2448, GSKB-pS21-S9, PDK-pS241 and growth factor receptors EGFR-pY1068 and ERBB-pY1248 – all exhibited increased phosphorylation (Fig. 3E)32,33.